Rajesh C. Shrotriya MD - 25 May 2022 Form 4 Insider Report for CASI Pharmaceuticals, Inc.

Role
Director
Signature
/s/Alexander A. Zukiwski, attorney-in-fact for Rajesh C. Shrotriya
Issuer symbol
N/A
Transactions as of
25 May 2022
Net transactions value
$0
Form type
4
Filing time
26 May 2022, 16:11:29 UTC
Previous filing
16 Jun 2021
Next filing
19 Jul 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CASI Stock Option (Right to Buy) Award $0 +345,806 $0.000000 345,806 25 May 2022 Common Stock 345,806 $0.4664 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Stock option award will vest ratably quarterly to the end of the year.

Remarks:

Exhibit 24 - Power Of Attorney